人工机械瓣膜置换术后低强度抗凝治疗
Low Intensity Anticoagulant Therapy after Prosthetic Mechanical Valve Replacement
DOI: 10.12677/ACM.2021.1111767, PDF,   
作者: 王 洋：延安大学附属医院，陕西 延安；张义和：延安大学附属医院东关心脑血管病医院心外科CCU，陕西 延安
关键词: 低强度；抗凝治疗；人工机械瓣膜置换；国际标准化比值(INR)；并发症；Low Intensity； Anticoagulation Therapy； Prosthetic Mechanical Valve Replacement； International Normalized Ratio； Complication
摘要: 人工机械瓣膜置换术术后患者往往需要终身服用药物抗凝治疗，而抗凝治疗强度与患者凝血功能情况和后期是否发生出血或栓塞并发症关系密切。对于术后患者来说制定合理抗凝目标至关重要，本文通过探讨低强度抗凝治疗在人工机械瓣膜置换术术后患者身上的发展及应用，做一综述，希望本文能对心脏机械瓣膜置换术后患者的低强度抗凝治疗提供理论支持。
Abstract: Patients after prosthetic mechanical valve replacement often require lifelong pharmacological anticoagulation therapy, and the intensity of anticoagulation therapy is closely related to the coagulation status of patients and whether bleeding or embolic complications occur. It is very important for postoperative patients to formulate reasonable anticoagulant goals. This paper discusses the development and application of low-intensity anticoagulant therapy in patients after prosthetic mechanical valve replacement. It is hoped that this paper can provide theoretical support for low-intensity anticoagulant therapy after mechanical heart valve replacement.
文章引用：王洋, 张义和. 人工机械瓣膜置换术后低强度抗凝治疗[J]. 临床医学进展, 2021, 11(11): 5196-5200. https://doi.org/10.12677/ACM.2021.1111767

参考文献

[1] 罗征祥. 心脏瓣膜病治疗的发展[J]. 岭南心血管病杂志, 2010, 16(5): 343+351.
[2] 陈洪. 江西赣南地区心脏机械瓣膜置换术后低强度抗凝治疗方法的临床研究与分析[D]: [硕士学位论文]. 南昌: 南昌大学, 2016.
[3] 中国结构性心脏病介入治疗进展报告编写组. 中国结构性心脏病介入治疗进展报告2020 [J]. 中国循环杂志, 2021, 36(9): 833-840.
[4] 武云龙, 王寅, 董念国. 瓣膜介入时代的思考——外科医生视角[J/OL]. 中国胸心血管外科临床杂志, 2021: 1-5. http://kns.cnki.net/kcms/detail/51.1492.R.20210820.1032.018.html, 2021-10-14.
[5] Cannegieter, S.C., Rosendaal, F.R. and Briët, E. (1994) Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses. Circulation, 89, 635-641. [Google Scholar] [CrossRef] [PubMed]
[6] Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., Delgado, V., Freemantle, N., Gilard, M., Haugaa Kristina, H., Jeppsson, A., Jüni, P., Pierard, L., Prendergast Bernard, D., Rafael, S.J., Tribouilloy C. and Wojakowski, W. (2021) 2021 ESC/EACTS Guidelines for the management of valvular heart disease. European Journal of Cardio-Thoracic Surgery, 60, 727-800. [Google Scholar] [CrossRef] [PubMed]
[7] Otto, C.M., Nishimura, R.A., Bonow, R.O.,Carabello, B.A., Erwin, J.P., Gentile, F., Jneid, H., Krieger, E.V., Mack, M., McLeod, C., O’Gara, P.T., Rigolin, V.H., Sundt Thoralf, M., Thompson, A., Toly, C., O’Gara, P.T., Beckman, J.A., Levine, G.N., Al-Khatib, S.M., Armbruster, A., Birtcher, K.K., Ciggaroa, J., Deswal, A., Dixon, D.L., Fleisher, L.A., de las Fuentes, L., Gentile, F., Goldberger, Z.D., Gorenek, B., Haynes, N., Hernandez, A.F., Hlatky, M.A., Joglar, J.A., Schuyler, J.W., Marine, J.E., Mark, D., Palaniappan, L., Piano, M.R., Spatz, E.S., Tamis-Holland, J., Wijeysundera, D.N., Joseph, W.Y. (2021) 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. The Journal of Thoracic and Cardiovascular Surgery, 162, e183-e353. [Google Scholar] [CrossRef] [PubMed]
[8] Oliva, B.E., Galán, A.P. and Pacheco, O.A.M. (2008) Comparison of Quality and Hemorragic Risk of Oral Anticoagulant Therapy Using Acenocoumarol versus Warfarin. Medicina Clinica, 131, 96-97. [Google Scholar] [CrossRef] [PubMed]
[9] 孙艺红. 华法林抗凝治疗的中国专家共识[J]. 中华内科杂志, 2013(1): 76-82.
[10] 刘洋, 徐志云, 张宝仁, 邹良建, 王志农, 于伟勇, 徐激斌. 259例应用国产C-L短柱侧倾碟瓣行二尖瓣置换术后15年随访[J]. 中国胸心血管外科临床杂志, 2008, 15(3): 161-164.
[11] 杜心灵, 张凯伦, 胡志伟, 罗军, 蓝鸿钧, 刘金平. 人工机械瓣膜置换术后合理抗凝强度的研究[J]. 中华胸心血管外科杂志, 2002, 18(6): 370.
[12] 张进华, 官超凡, 陈志杰, 田皇龙, 曹华. 华人心脏机械瓣膜置换术后不同强度华法林抗凝并发症发生率的系统评价[J]. 中国循证医学杂志, 2014, 14(11): 1361-1366.
[13] 孙晓刚, 胡盛寿, 祁国奇, 周玉燕. 805例国人St.Jude机械瓣膜置换术后低标准口服抗凝药物治疗的临床研究[J].中国循环杂志, 2002, 17(6): 26-28
[14] 付博, 董力, 石应康, 《瓣膜病术后抗凝个体化和低抗凝标准研究》课题组. 中国人心脏瓣膜置换术后抗凝治疗数据库建设[J]. 中国胸心血管外科临床杂志, 2013, 20(1): 3-9.
[15] 董力, 石应康, 田子朴, 马建旸, 王曦, 易军. 心脏机械瓣膜替换术后低强度抗凝治疗[J]. 中华外科杂志, 2004, 41(4): 250-252.
[16] 许建屏, 石应康, 董力, 魏宇, 付博, 刘若凡. 中国人心脏瓣膜置换术后低强度抗凝治疗3000例随访1年报告[J].四川大学学报(医学版), 2016, 47(1): 90-92.

为你推荐